EP 3762402 A1 20210113 - ANTI-PD-L1 VACCINE COMPOSITION
Title (en)
ANTI-PD-L1 VACCINE COMPOSITION
Title (de)
ANTI-PD-L1-IMPFSTOFFZUSAMMENSETZUNG
Title (fr)
COMPOSITION VACCINALE ANTI-PD-L1
Publication
Application
Priority
- FR 1851895 A 20180305
- EP 2019055463 W 20190305
Abstract (en)
[origin: WO2019170686A1] The present invention relates to a polypeptide which comprises or consists of - a first sequence consisting of at least 8 contiguous amino acid residues selected from within the sequence extending from amino acid residues 55 to 67 of the PD-L1 protein, and at most 30 contiguous amino acid residues selected from within the complete sequence of the PD-L1 protein; and/or - a second sequence consisting of at least 8 contiguous amino acid residues selected from within the sequence extending from amino acid residues 85 to 101 of the PD-L1 protein, and at most 30 contiguous amino acid residues selected from within the complete sequence of the PD-L1 protein; and/or - a third sequence consisting of at least 8 contiguous amino acid residues selected from within the sequence extending from amino acid residues 111 to 127 of the PD-L1 protein, and at most 30 contiguous amino acid residues selected from within the complete sequence of the PD-L1 protein; and/or - a fourth sequence consisting of at least 8 contiguous amino acid residues selected from within the sequence extending from amino acid residues 138 to 156 of the PD-L1 protein, and at most 30 contiguous amino acid residues selected from within the complete sequence of the PD-L1 protein; and/or - a fifth sequence consisting of at least 8 contiguous amino acid residues selected from within the sequence extending from amino acid residues 208 to 223 of the PD-L1 protein, and at most 30 contiguous amino acid residues selected from within the complete sequence of the PD-L1 protein.
IPC 8 full level
C07K 14/435 (2006.01); A61P 35/00 (2006.01); C07K 16/30 (2006.01)
CPC (source: EP US)
A61P 35/00 (2018.01 - EP); C07K 14/435 (2013.01 - EP); C07K 14/70532 (2013.01 - US); C07K 16/2827 (2013.01 - US); C07K 16/30 (2013.01 - EP); A61K 38/00 (2013.01 - US); A61K 39/00 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
FR 3078535 A1 20190906; FR 3078535 B1 20240209; CN 112739711 A 20210430; EP 3762402 A1 20210113; JP 2021517472 A 20210726; JP 2024077635 A 20240607; JP 7560365 B2 20241002; US 2021395368 A1 20211223; WO 2019170686 A1 20190912
DOCDB simple family (application)
FR 1851895 A 20180305; CN 201980029949 A 20190305; EP 19714323 A 20190305; EP 2019055463 W 20190305; JP 2020570637 A 20190305; JP 2024023145 A 20240219; US 201916978953 A 20190305